There are a few aspects that we would like to add to complement the discussion in EL-Arabey and Abdalla [1]. Firstly, the authors suggested that the reduction of weight with the use of metformin, especially among obese patients, may have a protective effect on mortality from COVID-19. This article is protected by copyright. All rights reserved.